Gary Whale - 18 May 2023 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role
Chief Technology Officer
Signature
/s/ Gary Whale
Issuer symbol
ZURA
Transactions as of
18 May 2023
Net transactions value
$0
Form type
4
Filing time
22 May 2023, 21:19:53 UTC
Previous filing
21 Mar 2023
Next filing
21 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZURA Employee Share Option (Right to Buy) Award $0 +95,329 $0.000000 95,329 18 May 2023 Class A Ordinary Shares 95,329 $0.0100 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Employee Share Option is a nil cost option granted under the Issuer's 2023 Equity Incentive Plan and the applicable UK Subplan.
F2 25% of the option shall become exercisable on May 18, 2024 and a further 2.083% of it shall become exercisable at the end of each month thereafter.